Kingdon Capital Management, L.L.C. En V Veno Medical Corp Transaction History
Kingdon Capital Management, L.L.C.
- $862 Million
- Q2 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in En V Veno Medical Corp stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 653,870 shares of NVNO stock, worth $2.22 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
653,870
Previous 653,870
-0.0%
Holding current value
$2.22 Million
Previous $3.56 Million
3.51%
% of portfolio
0.4%
Previous 0.43%
Shares
3 transactions
Others Institutions Holding NVNO
# of Institutions
32Shares Held
3.73MCall Options Held
98.5KPut Options Held
6.1K-
Perceptive Advisors LLC New York, NY623KShares$2.12 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT478KShares$1.62 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.36 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL231KShares$784,6860.07% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $32.2M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...